Viral hepatitis: Recent developments and prospects for prevention (Q36669150)

15 August 2017

1 reference

title

Viral hepatitis: recent developments and prospects for prevention (English)

1 reference

15 August 2017

Viral hepatitis: Recent developments and prospects for prevention (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(75)80118-1

21 December 2022

1 reference

S. Krugman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A171363

21 December 2022

language of work or name

English

0 references

publication date

1 December 1975

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:S0022347675801181?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(75)80118-1

https://api.elsevier.com/content/article/PII:S0022347675801181?httpAccept=text/plain

21 December 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(75)80118-1

The Journal of Pediatrics

21 December 2022

published in

1 reference

15 August 2017

volume

87

1 reference

15 August 2017

issue

6 Pt 2

1 reference

15 August 2017

page(s)

1067-1077

1 reference

The carrier state in viral hepatitis

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Infectious hepatitis; studies of its natural history and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Infectious hepatitis: detection of virus during the incubation period and in clinically inapparent infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

The natural history of infectious hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Hepatitis in marmosets: induction of disease with coded specimens from a human volunteer study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Recovery of Hepatitis Agents in the Marmoset from Human Cases Occurring in Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Etiologic relationship of marmoset-propagated CR326 hepatitis A virus to hepatitis in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Viral hepatitis, type A. Identification by specific complement fixation and immune adherence tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

A "NEW" ANTIGEN IN LEUKEMIA SERA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

An antigen detected in the blood during the incubation period of serum hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Relation of Australia-SH antigen to the willowbrook MS-2 strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Virus-like particles in sera of patients with infectious and serum hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Virus-like particles in serum of patients with Australia-antigen-associated hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

New antigen-antibody system in Australia-antigen-positive hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Antibody to hepatitis-B-virus core in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Hemagglutination Assay for Antigen and Antibody Associated with Viral Hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Duality of Hepatitis B Antigen and Its Antibody: I. Immunofluorescence Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Transmission of Type B Viral Hepatitis to Chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Radioimmunoassay for the detection of the core of the Dane particle and antibody to it.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Neonatal onset of the hepatitis-associated-antigen carrier state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

7 January 2021

Hepatitis B in Infants

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Hepatitis B surface antigen in the serum of infants after deliver from asymptomatic carrier mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Prevention of chronic neonatal hepatitis B virus infection with antibody to the hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Antibody to the Hepatitis B Surface Antigen in Immune Serum Globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Antibody against serum-hepatitis antigen. Prevalence and potential use as immune serum globulin in prevention of serum-hepatitis infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Hepatitis Virus: Effect of Heat on the Infectivity and Antigenicity of the MS-1 and MS-2 Strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Viral hepatitis, type B (MS-2 strain). Studies on active immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

A prospective study indicating that double-antibody radioimmunoassay reduces the incidence of post-transfusion hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Antibody Responses in Viral Hepatitis, Type B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Alteration of hepatitis B antigen (HB Ag) determinants by reduction and alkylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Viral subtypes and cross-protection in hepatitis B virus infections of chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Effects of Cyclophosphamide on Hepatitis B Virus Infection and Challenge in Chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

Specific Immune Adherence Assay for Human Hepatitis A Antibody. Application to Diagnostic and Epidemiologic Investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Purified and inactivated human hepatitis B vaccine: progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2875%2980118-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Characterization of CR326 human hepatitis A virus, a probable enterovirus

series ordinal

20

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(75)80118-1

A Specific Complement-Fixation Test for Human Hepatitis A Employing CR326 Virus Antigen. Diagnosis and Epidemiology

21 December 2022

series ordinal

21

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(75)80118-1

Infectious hepatitis: current status of prevention with gamma globulin

21 December 2022

series ordinal

49

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(75)80118-1

21 December 2022

Identifiers

1 reference

15 August 2017

1 reference